Associate Professor Sami Sokucu is a European board-certified specialist at VM Medical Park Florya, focusing on the surgical management of malignant bone tumours and complex cancer cases.

• Performs percutaneous radiofrequency ablation – a heat-based treatment that destroys bone tumours without the need for major surgery
• Expert in limb-sparing surgery for osteosarcoma and spinal tumours using local resection to manage pain and preserve function
• Fellow of the European Board of Orthopaedics and Traumatology (FEBOT)
• Faculty member at Istanbul Aydın University, having published over 20 international research papers on bone disorders

Professor Mehmet Karaca is a leading specialist at Medical Park Antalya, focusing on gynecological oncology and minimally invasive surgical techniques.

• Specialises in laparoscopic surgery for cervical, uterine, and ovarian cancers – using small incisions for faster recovery
• Trained in gynecological oncology surgery by the Turkish Ministry of Health
• Performs robotic-assisted procedures, including DaVinci robotic hysterectomies
• Former Clinical Chief at Antalya Training and Research Hospital
• Serves as a university professor, teaching next-generation cancer surgeons

Dr. Asawadech Sanbua

Medical Radiation​ Oncologist

• Passed palliative care training at the Karunrak Center. Khon Kaen University
  
   
• Certificate of oncotherm
  
   
• Expert in treating cancer with oncothermia machines (or hyperthermia machine) 5 years experience.
  
   
• 14 years of experience working in radiotherapy. Able to plan treatment (Planning 2D, 3D, IMRT, VMAT)
  
   
• Can provide chemical treatment, Chemotherapy, targeted drugs therapy) Immunotherapy (Immunotherapy) 

Professor Sağlam is a leading specialist in gastrointestinal oncology at Gayrettepe Florence Nightingale Hospital, where he leads the Medical Oncology Department.

• Focuses on complex gastrointestinal and neuroendocrine tumours – rare cancers of the hormone-producing cells
• Specialised in medical oncology at Istanbul University Oncology Institute
• Uses immunotherapy and targeted chemotherapy for advanced lung, bladder, and kidney cancers
• Member of the European Neuroendocrine Tumour Society (ENET) and ASCO